Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herceptin Concurrent With Radiation for HER2+ Breast Cancer
NCT00943410Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Mar 2000
- Primary completion
- Jan 2006
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Mar 2000; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00943410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00943410.